Stay updated on Subcutaneous Atezolizumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Subcutaneous Atezolizumab in NSCLC Clinical Trial page.

Latest updates to the Subcutaneous Atezolizumab in NSCLC Clinical Trial page
- CheckyesterdayChange DetectedThe record history adds Revision: v3.6.3 and removes Revision: v3.6.2. This marks a new release version for the history log of the study, without altering the underlying study data.SummaryDifference0.1%

- Check8 days agoChange DetectedA new revision entry v3.6.2 is added to the study record history. The previous revision entry v3.6.0 is removed from the visible history.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedRecruitment status updated to no longer seek participants, indicating enrollment has ended. The study record shows a new revision (v3.6.0) replacing the previous version (v3.5.5).SummaryDifference0.4%

- Check30 days agoChange DetectedA new revision entry v3.5.5 is added to the record history, signaling an updated version of the study record. The prior revision v3.5.4 is removed from the history list.SummaryDifference0.1%

- Check51 days agoChange DetectedRevision label at the bottom updated from v3.5.3 to v3.5.4, reflecting a new page build. This change affects page metadata and presentation but does not alter any trial data or content.SummaryDifference0.1%

- Check66 days agoChange DetectedThe page’s revision label changed from v3.5.2 to v3.5.3 in the footer, signaling a new release of the page’s record history. This is a minor update to the page’s versioning and does not alter the study details presented.SummaryDifference0.1%

Stay in the know with updates to Subcutaneous Atezolizumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Subcutaneous Atezolizumab in NSCLC Clinical Trial page.